0001021432-16-001266.txt : 20160518 0001021432-16-001266.hdr.sgml : 20160518 20160517174926 ACCESSION NUMBER: 0001021432-16-001266 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160518 DATE AS OF CHANGE: 20160517 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: A2M Regenerative Technologies, Inc. CENTRAL INDEX KEY: 0001644828 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 474460112 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-89118 FILM NUMBER: 161658740 BUSINESS ADDRESS: STREET 1: 215 APOLENA AVENUE CITY: NEWPORT BEACH STATE: CA ZIP: 92662 BUSINESS PHONE: 9496734510 MAIL ADDRESS: STREET 1: 215 APOLENA AVENUE CITY: NEWPORT BEACH STATE: CA ZIP: 92662 FORMER COMPANY: FORMER CONFORMED NAME: Southern Ridge Acquisition Corp DATE OF NAME CHANGE: 20150611 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Kasian Stefan CENTRAL INDEX KEY: 0001667113 FILING VALUES: FORM TYPE: SC 13D MAIL ADDRESS: STREET 1: 888 PROSPECT STREET STREET 2: #200 CITY: LA JOLLA STATE: CA ZIP: 92037 SC 13D 1 sc13dkasian.txt United States Securities and Exchange Commission Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) A2M REGENERATIVE TECHNOLOGIES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) None (CUSIP Number) Lee Cassidy 215 Apolena Avenue Newport Beach, CA 92662 ------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 20, 2015 ----------------------------------------------------- (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ====================================================================== CUSIP NO. None 13D Page 2 1. Name of Reporting Persons: ------------------------------------------------------------------- 2. Check the appropriate box if a member of a group: (a) (b) ------------------------------------------------------------------- 3. SEC use only ------------------------------------------------------------------- 4. Sourt of Funds PF ------------------------------------------------------------------- 5. Check if disclosure of legal proceeding is required pursuant to Itmes 2(d) or 2(e) [ ] ------------------------------------------------------------------- 6. Citizenship or place of organization: US ------------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. Sole Voting Power: 4,000,000 shares common indirectly owned ------------------------------------------------------------------- 8. Shared Voting Power: 0 ------------------------------------------------------------------- 9. Sole Dispositive Power: 4,000,000 shares ------------------------------------------------------------------- 10. Shared Dispositive Power: 0 ------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person 4,000,000 shares common ------------------------------------------------------------------- 12. Check if The Aggregate Amount in Row 11 Excludes Certain Shares. / / [ ] ------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row 11 47% (based on 8,500,000 shares outstanding) ------------------------------------------------------------------- 14. Type of Reporting Person: Individual ====================================================================== CUSIP NO. None 13D Page 3 Item 1 Security and Issuer (a) Name of Issuer: A2M REGENERATIVE TECHNOLOGIES, INC. (b) Address of Issuer's Principal Executive Offices: 888 Prospect Street, Suite 200 La Jolla, California 92037 (c) Common stock, $0.0001 par value per share ------------------------------------------------------------------- Item 2 Identity and Background (a) Name of Person Filing: Dr. Stefan Kasian (b) Address of Principal Business or, if none, Residence: 888 Prospect Street, Suite 200 La Jolla, California 92037 (c) Principal occupation or employment: Naturopathic medicine researcher, lecturer (d) During the past five years, Dr. Kasian has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) During the last five years, Dr. Kasian has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction which as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Citizenship: US ------------------------------------------------------------------- Item 3. Source and Amount of Funds or Other Consideration A company solely owned by Dr. Kasian received 4,000,000 shares at par as part of a change in control of the company. ------------------------------------------------------------------- Item 4. Purpose of transaction The shares were issued as part of a change in control of the Company. ------------------------------------------------------------------- Item 5. Interest in Securities of Issuer (a) As of the filing date of the Schedule 13D, Dr. Kasian (i) is the beneficial owner and (ii) has sole power to vote (iii) 4,000,000 shares ofcommon stock which represents approximately 47% of the 8,500,000 shares of common stock deemed to be outstanding pursuant to Rule 13d-1(j). (b) The responses to Items 7-11 of the cover page of this Schedule 13D are incorporated herein. (c) Except as set forth or incorporated herein, no other transaction in the common stock has been effected during the past 60 days. (d) Not applicable. (e) Not applicable. ------------------------------------------------------------------- Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer Not applicable. ------------------------------------------------------------------- Item 7. Materials to Be Filed as Exhibits Not applicable. ------------------------------------------------------------------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: May 17, 2016 /s/ Stefan Kasian -------------------------------------- Stefan Kasian